Tissue preservation system

US10039277B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10039277-B2
Application numberUS-201514946634-A
CountryUS
Kind codeB2
Filing dateNov 19, 2015
Priority dateJan 12, 2011
Publication dateAug 7, 2018
Grant dateAug 7, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a method and apparatus for tissue, such as an allograft, storage and preservation for extended periods of time at room temperature in a sterile tissue culture chamber. The invention further provides a process for maintaining the sterility of tissue using the apparatus as described.

First claim

Opening claim text (preview).

What is claimed is: 1. A process for osteochondral tissue preservation comprising storing the osteochondral tissue at room temperature in a container comprising a serum-free culture medium comprising dexamethasone for from about 7 days to about 70 days prior to implantation, wherein at least 70% of the cells of said osteochondral tissue remain viable after said storing compared to the viability of the cells of the osteochondral tissue at day 0. 2. The process of claim 1 , comprising testing the tissue for viability at least once prior to implantation in a patient. 3. The process of claim 2 , wherein testing for viability comprises assaying the culture medium withdrawn from said container. 4. The process of claim 2 , wherein testing for viability comprises adding a resazurin solution to the culture medium and determining a fluorescence level, wherein increased fluorescence indicates higher cell viability. 5. The process of claim 1 , comprising storing the tissue for from 29 to about 70 days. 6. The process of claim 1 comprising changing said culture medium at least once during the storing. 7. The process of claim 6 , comprising changing the culture medium about once every two weeks during the storing. 8. The process of claim 1 , wherein said culture medium comprises Dulbecco's Modified Eagle Medium (DMEM), high or low concentrations of glucose, antibiotic compounds, antimycotic compounds, ascorbate 2-phosphate, L-proline, sodium pyruvate, Transforming growth factor-β3 (TGF-β3), insulin, transferrin, and selenous acid. 9. The process of claim 1 , wherein the osteochondral tissue comprises an allograft, the process comprising storing the osteochondral tissue in a tissue preservation chamber comprising a base, lid, media inlet, and media outlet; wherein the media inlet is coupled to at least a first filter for maintaining a sterile environment inside the chamber; wherein the base is configured to contain the osteochondral tissue and media; the outlet extending into the chamber to permit removal of media; the media outlet comprising a one-way valve for exit of media from the chamber; wherein the base is capable of receiving the lid to form a barrier to contaminants. 10. The process of claim 9 , wherein the chamber comprises a gas exchange port coupled to at least a first filter. 11. The process of claim 10 , wherein the media inlet, media outlet and gas exchange port are comprised within the lid. 12. The process of claim 9 , comprising storing the tissue in the chamber for from about 29 days to about 60 days. 13. The process of claim 1 , wherein the osteochondral tissue comprises a section of spine, scapula, humerus, radius, ulna, pelvis, femur, tibia, patella, talus, phalanges or temporomandibular joint tissue. 14. The process of claim 1 , wherein the osteochondral tissue comprises an allograft, the process further comprising lavaging of the osteochondral tissue in an isotonic solution prior to said storing. 15. The process of claim 1 , further comprising implanting the tissue in a subject in need thereof following said storing. 16. A method for preserving osteochondral tissue at room temperature in a chamber comprising a serum-free culture medium comprising dexamethasone prior to implantation, the method comprising: placing the osteochondral tissue in a chamber base with said culture medium, the chamber base configured to maintain the tissue and the serum-free culture medium comprising dexamethasone; forming a tissue preservation chamber by covering the chamber base with a lid to form a barrier to contaminants, the chamber comprising at least one filter, a media inlet coupled to at least one filter for maintaining a sterile environment inside the chamber, and a media outlet, the media outlet including a media outlet conduit that extends into the chamber to permit removal of media; wherein the media outlet comprises a one-way valve to prevent reentry of culture medium exiting the chamber; and storing the osteochondral tissue at room temperature for from about 7 days to about 70 days prior to implantation, wherein at least 70% of the cells of said osteochondral tissue remain viable after said storing compared to the viability of the cells of the osteochondral tissue at day 0. 17. The method of claim 16 , wherein the chamber further comprises a gas exchange port coupled to at least one filter. 18. The method of claim 17 , wherein the lid comprises the media inlet, media outlet, and gas exchange port. 19. The method of claim 16 , comprising adding the culture medium to the chamber by forcing through the media inlet and at least one filter. 20. The method of claim 19 , further comprising storing the tissue in the chamber for from 29 days to about 70 days. 21. The method of claim 20 , further comprising removing the culture medium from the chamber through the media outlet. 22. The method of claim 20 , further comprising simultaneously adding the culture medium to the chamber by forcing through the media inlet and at least one filter and removing the medium from the chamber through the media outlet. 23. The method of claim 20 , further comprising applying tamper evident tape to an interface between the chamber base and the lid.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10039277B2 cover?
The present invention provides a method and apparatus for tissue, such as an allograft, storage and preservation for extended periods of time at room temperature in a sterile tissue culture chamber. The invention further provides a process for maintaining the sterility of tissue using the apparatus as described.
Who is the assignee on this patent?
Univ Missouri, Univ Columbia
What technology area does this patent fall under?
Primary CPC classification A01N1/0226. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).